SGRY

Surgery Partners (SGRY) surged 48% after HealthSpan Partners announced a $5.7 billion all-cash acquisition at $23.50 per share. The stock now trades just below the acquisition price, suggesting market confidence in deal completion expected in Q1 2027. However, the valuation represents a buy-low opportunity for the acquirer, as shares are near levels from a year ago.

The Nasdaq rose 0.82% on October 26, 2026, driven by AI optimism following Anthropic's IPO filing. Tesla surged 5% on a Barclays upgrade, while Meta fell 2% after announcing a $95 billion AI infrastructure investment plan. The S&P 500 gained 0.70% and the Dow edged up 0.28% as investors favored tech and real estate stocks.